Collegium制药是一家专科制药企业,专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法,主要面向美国市场,推出适用于慢性疼痛患者的缓释镇痛产品,服务覆盖基层及专科医疗领域的医护人员。
RARE
Ultragenyx Pharmaceutical Inc.
营收
$207.3M
净利润
$-128.6M
IONS
IONIS PHARMACEUTICALS INC
$203.3M
$-229.4M
IDYA
IDEAYA Biosciences, Inc.
$207.8M
$119.2M
CSV
CARRIAGE SERVICES INC
$105.5M
$12.3M
KNSA
Kiniksa Pharmaceuticals International, plc
$202.1M
$14.2M
CORT
CORCEPT THERAPEUTICS INC
$24.3M
FRD
FRIEDMAN INDUSTRIES INC
$168.0M
$3.0M
APLS
Apellis Pharmaceuticals, Inc.
$199.9M
$-59.0M